HEALTH CATALYST INC

Ticker: HCAT CUSIP: 42225T107 Class: Common Stock

Rhenman & Partners Asset Management AB's Holding History (CIK: 0001599882)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 300,000 Value ($000) $2,778 Avg Close $8.17 Range $6.60 - $10.20
Q3 2023
Shares 320,000 Value ($000) $3,238 Avg Close $11.94 Range $9.25 - $14.37
Q2 2023
Shares 320,000 Value ($000) $4,000 Avg Close $11.91 Range $9.45 - $13.34
Q1 2023
Shares 340,000 Value ($000) $3,869 Avg Close $12.75 Range $9.90 - $15.87
Q4 2022
Shares 180,000 Value ($000) $1,913 Avg Close $9.65 Range $6.40 - $11.63
Q3 2022
Shares 180,000 Value ($000) $1,588 Avg Close $13.24 Range $9.03 - $18.30
Q2 2022
Shares 180,000 Value ($000) $2,608 Avg Close $17.05 Range $11.25 - $27.98
Q1 2022
Shares 180,000 Value ($000) $4,703 Avg Close $28.37 Range $20.39 - $40.65
Q4 2021
Shares 240,000 Value ($000) $9,734 Avg Close $45.57 Range $35.95 - $54.27
Q3 2021
Shares 240,000 Value ($000) $12,002 Avg Close $54.54 Range $49.23 - $59.50
Q2 2021
Shares 240,000 Value ($000) $13,322 Avg Close $53.27 Range $46.19 - $59.50
Q1 2021
Shares 115,000 Value ($000) $5,379 Avg Close $48.44 Range $41.78 - $55.07